Has the Recent Equifax Price Drop Unlocked a Better Value for Investors in 2025?

November 7, 2025

  • Wondering if Equifax is a bargain or overpriced? You are not alone, and there has never been a better time to take a closer look at its true value.

  • The stock has slid by 1.7% over the last week and is down 13.4% for the month, adding up to a challenging year-to-date return of -17.3%. However, longer-term investors have still seen gains of 9.3% over three years and 30.3% over five years.

  • Recent headlines highlight increased scrutiny in the credit reporting industry, with Equifax responding to changing regulatory dynamics and emphasizing investments in new technologies to strengthen data integrity. This broader context provides important clues into both the risks and future growth prospects currently being weighed by the market.

  • On the valuation front, Equifax scores a 3 out of 6 on our checks for undervaluation. Whether this provides the full picture, or if there is a smarter way to judge value, is what we will dig into next. Keep reading for deeper insights and a fresh perspective on what really drives fair value.

Find out why Equifax’s -22.8% return over the last year is lagging behind its peers.

The Discounted Cash Flow (DCF) model estimates a company’s intrinsic value by projecting its future free cash flows and discounting them back to today’s dollars. This approach is widely used as it attempts to capture both current performance and growth potential based on realistic assumptions.

For Equifax, the DCF model begins with the company’s latest reported Free Cash Flow (FCF) of $891.95 million. According to analyst estimates compiled for the next five years, FCF is forecasted to steadily grow, reaching $1.12 billion in 2026 and climbing to a projected $1.81 billion by 2029. Beyond that, further growth projections are extrapolated, reaching close to $1.92 billion by 2035. These figures are all modeled in US dollars and rely on a combination of analyst consensus and forward-looking estimates.

When all projected future cash flows are discounted back using appropriate rates, the DCF analysis estimates Equifax’s fair value at $279.78 per share. This compares to current trading levels and suggests the stock is about 25.8 percent undervalued, indicating there could be potential upside if the cash flow projections are realized.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Equifax is undervalued by 25.8%. Track this in your watchlist or portfolio, or discover 870 more undervalued stocks based on cash flows.

EFX Discounted Cash Flow as at Nov 2025
EFX Discounted Cash Flow as at Nov 2025

Head to the Valuation section of our Company Report for more details on how we arrive at this Fair Value for Equifax.

The Price-to-Earnings (PE) ratio is widely used to value profitable companies because it ties a company’s current share price to its bottom-line performance. For businesses like Equifax that consistently deliver earnings, the PE ratio helps investors gauge whether the stock is cheap or expensive relative to the profits it is generating.

It is important to note that a “normal” or “fair” PE ratio is shaped by more than just today’s profits. Higher growth expectations or lower risk can justify a higher PE, since investors are willing to pay up for future earnings potential. Similarly, companies facing uncertainty or with slower growth prospects usually trade at a lower PE ratio.

As of now, Equifax trades on a PE ratio of 38.6x. This is notably above the Professional Services industry average of 24.6x and also higher than the peer group average of 34.6x. To add nuance, Simply Wall St calculates a proprietary Fair Ratio for each stock. In this case, it is 32.2x. The Fair Ratio is designed to reflect a more comprehensive view than a simple peer or industry comparison by factoring in Equifax’s growth outlook, risk profile, profit margins, industry membership, and market capitalization.

Because the Fair Ratio accounts for specific qualities of the company rather than just averaging across the sector, it provides a clearer picture of what a reasonable valuation should be. Since Equifax’s current PE of 38.6x is significantly above its Fair Ratio of 32.2x, the stock appears to be overvalued based on this multiple.

Result: OVERVALUED

NYSE:EFX PE Ratio as at Nov 2025
NYSE:EFX PE Ratio as at Nov 2025

PE ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1395 companies where insiders are betting big on explosive growth.

Earlier, we mentioned that there is an even better way to understand valuation, so let’s introduce you to Narratives. A Narrative is your personal story or perspective about a company, connecting what you believe about Equifax’s future, such as revenue, profit margins, or its competitive edge, to a tailored financial forecast and resulting in your own estimate of fair value.

Narratives help make sense of all the numbers by linking what is happening in the real world to your investment decisions, giving context to metrics like PE ratios. On Simply Wall St’s Community page, millions of investors use Narratives as an easy, interactive tool to express their assumptions and see how changes in a company’s story affect fair value in real time.

Importantly, Narratives are dynamic, as they update automatically when news breaks or earnings are announced, so your assumptions and analysis stay relevant. Suppose you believe Equifax will overcome new competition and regulatory shifts, maintaining strong margin growth and capturing new markets: your Narrative could point to a fair value as high as $300 per share. On the other hand, if you expect margin pressures and slowed revenue, you might see fair value closer to $240. Narratives empower you to compare your own fair value to the current share price, helping you decide when to buy or sell with confidence.

Do you think there’s more to the story for Equifax? Head over to our Community to see what others are saying!

NYSE:EFX Community Fair Values as at Nov 2025
NYSE:EFX Community Fair Values as at Nov 2025

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include EFX.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Terms and Privacy Policy


 

Search

RECENT PRESS RELEASES